Volastra Therapeutics Funding & Investors
New York, NY
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.
volastratx.comTotal Amount Raised: $119,000,000
Volastra Therapeutics Funding Rounds
Series Unknown
$15,000,000
Series A
$60,000,000
Series A Investors
Arch Venture PartnersEli Lilly and CompanyPolaris PartnersMeyer VenturesVida VenturesCatalio Capital ManagementDroia VenturesCornell UniversitySeed
$32,000,000
Seed Investors
Catalio Capital ManagementVida VenturesArch Venture PartnersQuark VentureDroia VenturesPolaris PartnersSeed
$12,000,000
Seed Investors
Polaris PartnersDroia VenturesGF SecuritiesArch Venture PartnersQuark VentureGlobal Health Sciences Venture Fund
Funding info provided by Diffbot.